nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—KIT—germ cell cancer	0.419	1	CbGaD
Regorafenib—UGT1A1—Etoposide—germ cell cancer	0.0343	0.12	CbGbCtD
Regorafenib—ABCG2—Dactinomycin—germ cell cancer	0.0335	0.117	CbGbCtD
Regorafenib—CYP2B6—Ifosfamide—germ cell cancer	0.0278	0.0974	CbGbCtD
Regorafenib—CYP2C8—Ifosfamide—germ cell cancer	0.0211	0.0738	CbGbCtD
Regorafenib—ABCG2—Cisplatin—germ cell cancer	0.0192	0.0674	CbGbCtD
Regorafenib—ABCG2—Etoposide—germ cell cancer	0.0189	0.0662	CbGbCtD
Regorafenib—CYP2C19—Ifosfamide—germ cell cancer	0.0177	0.0619	CbGbCtD
Regorafenib—CYP2C9—Ifosfamide—germ cell cancer	0.0147	0.0515	CbGbCtD
Regorafenib—CYP2B6—Cisplatin—germ cell cancer	0.0135	0.0474	CbGbCtD
Regorafenib—ABCG2—Methotrexate—germ cell cancer	0.0125	0.0437	CbGbCtD
Regorafenib—ABCB1—Dactinomycin—germ cell cancer	0.0121	0.0423	CbGbCtD
Regorafenib—CYP2C8—Etoposide—germ cell cancer	0.0101	0.0353	CbGbCtD
Regorafenib—CYP3A4—Ifosfamide—germ cell cancer	0.00854	0.0299	CbGbCtD
Regorafenib—ABCB1—Vinblastine—germ cell cancer	0.00756	0.0265	CbGbCtD
Regorafenib—CYP2C9—Cisplatin—germ cell cancer	0.00714	0.025	CbGbCtD
Regorafenib—ABCB1—Cisplatin—germ cell cancer	0.00693	0.0243	CbGbCtD
Regorafenib—ABCB1—Etoposide—germ cell cancer	0.00681	0.0239	CbGbCtD
Regorafenib—CYP3A4—Vinblastine—germ cell cancer	0.00453	0.0159	CbGbCtD
Regorafenib—ABCB1—Methotrexate—germ cell cancer	0.0045	0.0158	CbGbCtD
Regorafenib—CYP3A4—Etoposide—germ cell cancer	0.00408	0.0143	CbGbCtD
Regorafenib—Posterior reversible encephalopathy syndrome—Ifosfamide—germ cell cancer	0.00368	0.0471	CcSEcCtD
Regorafenib—Posterior reversible encephalopathy syndrome—Cisplatin—germ cell cancer	0.00317	0.0406	CcSEcCtD
Regorafenib—Sorafenib—KIT—germ cell cancer	0.00265	1	CrCbGaD
Regorafenib—Mucosal inflammation—Bleomycin—germ cell cancer	0.00128	0.0163	CcSEcCtD
Regorafenib—Hypomagnesaemia—Bleomycin—germ cell cancer	0.00111	0.0142	CcSEcCtD
Regorafenib—Amylase increased—Cisplatin—germ cell cancer	0.00109	0.014	CcSEcCtD
Regorafenib—Mucosal inflammation—Ifosfamide—germ cell cancer	0.00109	0.014	CcSEcCtD
Regorafenib—Nail disorder—Bleomycin—germ cell cancer	0.00109	0.0139	CcSEcCtD
Regorafenib—Hypophosphataemia—Ifosfamide—germ cell cancer	0.00104	0.0133	CcSEcCtD
Regorafenib—Polyp—Ifosfamide—germ cell cancer	0.000992	0.0127	CcSEcCtD
Regorafenib—Nail disorder—Ifosfamide—germ cell cancer	0.00093	0.0119	CcSEcCtD
Regorafenib—Cyst—Ifosfamide—germ cell cancer	0.000903	0.0116	CcSEcCtD
Regorafenib—Hypophosphataemia—Cisplatin—germ cell cancer	0.000895	0.0115	CcSEcCtD
Regorafenib—Mucosal inflammation—Etoposide—germ cell cancer	0.000861	0.011	CcSEcCtD
Regorafenib—Hepatotoxicity—Dactinomycin—germ cell cancer	0.000853	0.0109	CcSEcCtD
Regorafenib—Hepatotoxicity—Ifosfamide—germ cell cancer	0.000782	0.01	CcSEcCtD
Regorafenib—Neoplasm—Vinblastine—germ cell cancer	0.000756	0.00968	CcSEcCtD
Regorafenib—Nail disorder—Etoposide—germ cell cancer	0.000735	0.00941	CcSEcCtD
Regorafenib—Endocrine disorder—Ifosfamide—germ cell cancer	0.000728	0.00932	CcSEcCtD
Regorafenib—Hypocalcaemia—Dactinomycin—germ cell cancer	0.000719	0.00921	CcSEcCtD
Regorafenib—Proteinuria—Ifosfamide—germ cell cancer	0.000687	0.00879	CcSEcCtD
Regorafenib—Protein urine present—Ifosfamide—germ cell cancer	0.000677	0.00867	CcSEcCtD
Regorafenib—Hepatotoxicity—Cisplatin—germ cell cancer	0.000674	0.00863	CcSEcCtD
Regorafenib—Hypocalcaemia—Ifosfamide—germ cell cancer	0.000659	0.00844	CcSEcCtD
Regorafenib—Liver injury—Cisplatin—germ cell cancer	0.000618	0.00792	CcSEcCtD
Regorafenib—Hepatotoxicity—Etoposide—germ cell cancer	0.000617	0.0079	CcSEcCtD
Regorafenib—Hyperuricaemia—Cisplatin—germ cell cancer	0.000561	0.00718	CcSEcCtD
Regorafenib—Neoplasm—Ifosfamide—germ cell cancer	0.000546	0.00698	CcSEcCtD
Regorafenib—Blood uric acid increased—Cisplatin—germ cell cancer	0.00053	0.00678	CcSEcCtD
Regorafenib—Mucosal inflammation—Methotrexate—germ cell cancer	0.000516	0.0066	CcSEcCtD
Regorafenib—Hyperuricaemia—Etoposide—germ cell cancer	0.000514	0.00658	CcSEcCtD
Regorafenib—Blood uric acid increased—Etoposide—germ cell cancer	0.000485	0.00621	CcSEcCtD
Regorafenib—Polyp—Methotrexate—germ cell cancer	0.000469	0.00601	CcSEcCtD
Regorafenib—Acute coronary syndrome—Vinblastine—germ cell cancer	0.000461	0.0059	CcSEcCtD
Regorafenib—Myocardial infarction—Vinblastine—germ cell cancer	0.000458	0.00587	CcSEcCtD
Regorafenib—Nail disorder—Methotrexate—germ cell cancer	0.00044	0.00564	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00043	0.00551	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00043	0.00551	CcSEcCtD
Regorafenib—Cyst—Methotrexate—germ cell cancer	0.000427	0.00547	CcSEcCtD
Regorafenib—Haemoglobin—Vinblastine—germ cell cancer	0.000422	0.0054	CcSEcCtD
Regorafenib—Haemorrhage—Vinblastine—germ cell cancer	0.00042	0.00537	CcSEcCtD
Regorafenib—Weight decreased—Bleomycin—germ cell cancer	0.000401	0.00513	CcSEcCtD
Regorafenib—Hypokalaemia—Ifosfamide—germ cell cancer	0.000399	0.0051	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.000394	0.00505	CcSEcCtD
Regorafenib—Acute coronary syndrome—Bleomycin—germ cell cancer	0.000389	0.00498	CcSEcCtD
Regorafenib—Myocardial infarction—Bleomycin—germ cell cancer	0.000387	0.00496	CcSEcCtD
Regorafenib—Neutropenia—Dactinomycin—germ cell cancer	0.000386	0.00495	CcSEcCtD
Regorafenib—Stomatitis—Bleomycin—germ cell cancer	0.000385	0.00493	CcSEcCtD
Regorafenib—Hyponatraemia—Cisplatin—germ cell cancer	0.000379	0.00485	CcSEcCtD
Regorafenib—Alopecia—Vinblastine—germ cell cancer	0.000371	0.00475	CcSEcCtD
Regorafenib—Hepatotoxicity—Methotrexate—germ cell cancer	0.00037	0.00473	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.000365	0.00468	CcSEcCtD
Regorafenib—Stomatitis—Dactinomycin—germ cell cancer	0.000359	0.0046	CcSEcCtD
Regorafenib—Haemoglobin—Bleomycin—germ cell cancer	0.000356	0.00456	CcSEcCtD
Regorafenib—Haemorrhage—Bleomycin—germ cell cancer	0.000355	0.00454	CcSEcCtD
Regorafenib—Hypokalaemia—Cisplatin—germ cell cancer	0.000344	0.0044	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00034	0.00435	CcSEcCtD
Regorafenib—Anaemia—Vinblastine—germ cell cancer	0.000338	0.00432	CcSEcCtD
Regorafenib—Infestation NOS—Ifosfamide—germ cell cancer	0.000338	0.00432	CcSEcCtD
Regorafenib—Infestation—Ifosfamide—germ cell cancer	0.000338	0.00432	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.000335	0.00428	CcSEcCtD
Regorafenib—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.000333	0.00426	CcSEcCtD
Regorafenib—Myocardial infarction—Ifosfamide—germ cell cancer	0.000331	0.00424	CcSEcCtD
Regorafenib—Stomatitis—Ifosfamide—germ cell cancer	0.000329	0.00421	CcSEcCtD
Regorafenib—Leukopenia—Vinblastine—germ cell cancer	0.000327	0.00419	CcSEcCtD
Regorafenib—Proteinuria—Methotrexate—germ cell cancer	0.000325	0.00416	CcSEcCtD
Regorafenib—Protein urine present—Methotrexate—germ cell cancer	0.00032	0.0041	CcSEcCtD
Regorafenib—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000319	0.00409	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Methotrexate—germ cell cancer	0.000318	0.00407	CcSEcCtD
Regorafenib—Hypertension—Vinblastine—germ cell cancer	0.000316	0.00404	CcSEcCtD
Regorafenib—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.000314	0.00402	CcSEcCtD
Regorafenib—Alopecia—Bleomycin—germ cell cancer	0.000313	0.00401	CcSEcCtD
Regorafenib—Erythema multiforme—Dactinomycin—germ cell cancer	0.000313	0.004	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000312	0.00399	CcSEcCtD
Regorafenib—Hyperuricaemia—Methotrexate—germ cell cancer	0.000308	0.00394	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000305	0.00391	CcSEcCtD
Regorafenib—Haemoglobin—Ifosfamide—germ cell cancer	0.000305	0.0039	CcSEcCtD
Regorafenib—Haemorrhage—Ifosfamide—germ cell cancer	0.000303	0.00388	CcSEcCtD
Regorafenib—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000299	0.00383	CcSEcCtD
Regorafenib—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000298	0.00381	CcSEcCtD
Regorafenib—Urethral disorder—Ifosfamide—germ cell cancer	0.000297	0.0038	CcSEcCtD
Regorafenib—Alopecia—Dactinomycin—germ cell cancer	0.000292	0.00374	CcSEcCtD
Regorafenib—Thrombocytopenia—Vinblastine—germ cell cancer	0.000292	0.00374	CcSEcCtD
Regorafenib—TEK—decidua—germ cell cancer	0.000291	0.00291	CbGeAlD
Regorafenib—Blood uric acid increased—Methotrexate—germ cell cancer	0.000291	0.00372	CcSEcCtD
Regorafenib—EPHX2—female gonad—germ cell cancer	0.000287	0.00287	CbGeAlD
Regorafenib—Acute coronary syndrome—Cisplatin—germ cell cancer	0.000287	0.00367	CcSEcCtD
Regorafenib—Erythema multiforme—Ifosfamide—germ cell cancer	0.000287	0.00367	CcSEcCtD
Regorafenib—Anaemia—Bleomycin—germ cell cancer	0.000285	0.00365	CcSEcCtD
Regorafenib—Myocardial infarction—Cisplatin—germ cell cancer	0.000285	0.00365	CcSEcCtD
Regorafenib—Stomatitis—Cisplatin—germ cell cancer	0.000284	0.00363	CcSEcCtD
Regorafenib—KIT—trigeminal ganglion—germ cell cancer	0.000283	0.00283	CbGeAlD
Regorafenib—DDR2—brain—germ cell cancer	0.000283	0.00283	CbGeAlD
Regorafenib—RAF1—skin of body—germ cell cancer	0.000282	0.00282	CbGeAlD
Regorafenib—FLT1—decidua—germ cell cancer	0.000281	0.00282	CbGeAlD
Regorafenib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000281	0.0036	CcSEcCtD
Regorafenib—RAF1—decidua—germ cell cancer	0.00028	0.0028	CbGeAlD
Regorafenib—Neutropenia—Etoposide—germ cell cancer	0.00028	0.00358	CcSEcCtD
Regorafenib—PDGFRA—telencephalon—germ cell cancer	0.000278	0.00278	CbGeAlD
Regorafenib—FLT4—adrenal gland—germ cell cancer	0.000278	0.00278	CbGeAlD
Regorafenib—PDGFRB—trigeminal ganglion—germ cell cancer	0.000277	0.00277	CbGeAlD
Regorafenib—Leukopenia—Bleomycin—germ cell cancer	0.000276	0.00354	CcSEcCtD
Regorafenib—KDR—eye—germ cell cancer	0.000275	0.00276	CbGeAlD
Regorafenib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000275	0.00352	CcSEcCtD
Regorafenib—Angiopathy—Ifosfamide—germ cell cancer	0.000275	0.00352	CcSEcCtD
Regorafenib—RET—pituitary gland—germ cell cancer	0.000274	0.00275	CbGeAlD
Regorafenib—FGFR1—adrenal gland—germ cell cancer	0.000274	0.00274	CbGeAlD
Regorafenib—KIT—embryo—germ cell cancer	0.000273	0.00274	CbGeAlD
Regorafenib—DDR2—lymph node—germ cell cancer	0.000273	0.00274	CbGeAlD
Regorafenib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000273	0.0035	CcSEcCtD
Regorafenib—KDR—retina—germ cell cancer	0.000273	0.00273	CbGeAlD
Regorafenib—FGFR1—midbrain—germ cell cancer	0.00027	0.00271	CbGeAlD
Regorafenib—FLT4—bone marrow—germ cell cancer	0.000269	0.00269	CbGeAlD
Regorafenib—MAPK11—brain—germ cell cancer	0.000268	0.00268	CbGeAlD
Regorafenib—Alopecia—Ifosfamide—germ cell cancer	0.000268	0.00343	CcSEcCtD
Regorafenib—PDGFRB—embryo—germ cell cancer	0.000267	0.00267	CbGeAlD
Regorafenib—Infestation NOS—Etoposide—germ cell cancer	0.000267	0.00341	CcSEcCtD
Regorafenib—Infestation—Etoposide—germ cell cancer	0.000267	0.00341	CcSEcCtD
Regorafenib—BRAF—testis—germ cell cancer	0.000266	0.00267	CbGeAlD
Regorafenib—Anaemia—Dactinomycin—germ cell cancer	0.000266	0.00341	CcSEcCtD
Regorafenib—FGFR2—uterus—germ cell cancer	0.000266	0.00266	CbGeAlD
Regorafenib—RET—medulla oblongata—germ cell cancer	0.000265	0.00265	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000264	0.00338	CcSEcCtD
Regorafenib—FGFR1—spinal cord—germ cell cancer	0.000264	0.00264	CbGeAlD
Regorafenib—Malnutrition—Ifosfamide—germ cell cancer	0.000264	0.00338	CcSEcCtD
Regorafenib—PDGFRA—decidua—germ cell cancer	0.000264	0.00264	CbGeAlD
Regorafenib—Acute coronary syndrome—Etoposide—germ cell cancer	0.000263	0.00336	CcSEcCtD
Regorafenib—Myocardial infarction—Etoposide—germ cell cancer	0.000261	0.00335	CcSEcCtD
Regorafenib—Stomatitis—Etoposide—germ cell cancer	0.00026	0.00333	CcSEcCtD
Regorafenib—Decreased appetite—Vinblastine—germ cell cancer	0.000259	0.00332	CcSEcCtD
Regorafenib—MAPK11—lymph node—germ cell cancer	0.000259	0.00259	CbGeAlD
Regorafenib—FLT4—female gonad—germ cell cancer	0.000259	0.00259	CbGeAlD
Regorafenib—Neoplasm—Methotrexate—germ cell cancer	0.000258	0.0033	CcSEcCtD
Regorafenib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000258	0.0033	CcSEcCtD
Regorafenib—Leukopenia—Dactinomycin—germ cell cancer	0.000258	0.0033	CcSEcCtD
Regorafenib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000257	0.00329	CcSEcCtD
Regorafenib—EPHA2—pituitary gland—germ cell cancer	0.000256	0.00257	CbGeAlD
Regorafenib—Urethral disorder—Cisplatin—germ cell cancer	0.000256	0.00328	CcSEcCtD
Regorafenib—FGFR1—female gonad—germ cell cancer	0.000255	0.00256	CbGeAlD
Regorafenib—Pain—Vinblastine—germ cell cancer	0.000255	0.00327	CcSEcCtD
Regorafenib—EPHX2—testis—germ cell cancer	0.000255	0.00255	CbGeAlD
Regorafenib—TEK—uterus—germ cell cancer	0.000255	0.00255	CbGeAlD
Regorafenib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000252	0.00323	CcSEcCtD
Regorafenib—KIT—brainstem—germ cell cancer	0.000251	0.00251	CbGeAlD
Regorafenib—Infection—Bleomycin—germ cell cancer	0.00025	0.0032	CcSEcCtD
Regorafenib—TEK—pituitary gland—germ cell cancer	0.00025	0.0025	CbGeAlD
Regorafenib—FLT1—gonad—germ cell cancer	0.000248	0.00248	CbGeAlD
Regorafenib—Thrombocytopenia—Bleomycin—germ cell cancer	0.000247	0.00316	CcSEcCtD
Regorafenib—ABL1—trigeminal ganglion—germ cell cancer	0.000247	0.00247	CbGeAlD
Regorafenib—RAF1—gonad—germ cell cancer	0.000246	0.00247	CbGeAlD
Regorafenib—FLT1—uterus—germ cell cancer	0.000246	0.00246	CbGeAlD
Regorafenib—BRAF—cerebellum—germ cell cancer	0.000246	0.00246	CbGeAlD
Regorafenib—RET—adrenal gland—germ cell cancer	0.000245	0.00245	CbGeAlD
Regorafenib—RAF1—uterus—germ cell cancer	0.000245	0.00245	CbGeAlD
Regorafenib—UGT1A9—endocrine gland—germ cell cancer	0.000244	0.00244	CbGeAlD
Regorafenib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000244	0.00312	CcSEcCtD
Regorafenib—Anaemia—Ifosfamide—germ cell cancer	0.000244	0.00312	CcSEcCtD
Regorafenib—Cardiac disorder—Cisplatin—germ cell cancer	0.000242	0.0031	CcSEcCtD
Regorafenib—RET—midbrain—germ cell cancer	0.000242	0.00242	CbGeAlD
Regorafenib—FLT1—pituitary gland—germ cell cancer	0.000242	0.00242	CbGeAlD
Regorafenib—TEK—medulla oblongata—germ cell cancer	0.000241	0.00241	CbGeAlD
Regorafenib—FLT4—endocrine gland—germ cell cancer	0.000241	0.00241	CbGeAlD
Regorafenib—RAF1—pituitary gland—germ cell cancer	0.00024	0.00241	CbGeAlD
Regorafenib—PDGFRB—eye—germ cell cancer	0.000238	0.00238	CbGeAlD
Regorafenib—ABL1—embryo—germ cell cancer	0.000238	0.00238	CbGeAlD
Regorafenib—KDR—decidua—germ cell cancer	0.000238	0.00238	CbGeAlD
Regorafenib—FLT4—head—germ cell cancer	0.000238	0.00238	CbGeAlD
Regorafenib—Urinary tract disorder—Etoposide—germ cell cancer	0.000236	0.00303	CcSEcCtD
Regorafenib—RET—spinal cord—germ cell cancer	0.000236	0.00236	CbGeAlD
Regorafenib—Leukopenia—Ifosfamide—germ cell cancer	0.000236	0.00302	CcSEcCtD
Regorafenib—Abdominal pain—Vinblastine—germ cell cancer	0.000236	0.00302	CcSEcCtD
Regorafenib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000235	0.00301	CcSEcCtD
Regorafenib—EPHX2—cerebellum—germ cell cancer	0.000235	0.00235	CbGeAlD
Regorafenib—Urethral disorder—Etoposide—germ cell cancer	0.000235	0.003	CcSEcCtD
Regorafenib—Infection—Dactinomycin—germ cell cancer	0.000233	0.00299	CcSEcCtD
Regorafenib—FLT1—medulla oblongata—germ cell cancer	0.000233	0.00233	CbGeAlD
Regorafenib—FGFR2—adrenal gland—germ cell cancer	0.000233	0.00233	CbGeAlD
Regorafenib—PDGFRA—gonad—germ cell cancer	0.000232	0.00232	CbGeAlD
Regorafenib—RAF1—medulla oblongata—germ cell cancer	0.000232	0.00232	CbGeAlD
Regorafenib—Alopecia—Cisplatin—germ cell cancer	0.000231	0.00296	CcSEcCtD
Regorafenib—PDGFRA—uterus—germ cell cancer	0.000231	0.00231	CbGeAlD
Regorafenib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00023	0.00294	CcSEcCtD
Regorafenib—FLT4—testis—germ cell cancer	0.00023	0.0023	CbGeAlD
Regorafenib—EPHA2—adrenal gland—germ cell cancer	0.000229	0.00229	CbGeAlD
Regorafenib—Hypertension—Ifosfamide—germ cell cancer	0.000228	0.00292	CcSEcCtD
Regorafenib—Malnutrition—Cisplatin—germ cell cancer	0.000227	0.00291	CcSEcCtD
Regorafenib—FGFR1—testis—germ cell cancer	0.000227	0.00227	CbGeAlD
Regorafenib—Erythema multiforme—Etoposide—germ cell cancer	0.000226	0.0029	CcSEcCtD
Regorafenib—FGFR2—spinal cord—germ cell cancer	0.000224	0.00225	CbGeAlD
Regorafenib—TEK—adrenal gland—germ cell cancer	0.000223	0.00224	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000223	0.00286	CcSEcCtD
Regorafenib—KIT—telencephalon—germ cell cancer	0.000222	0.00223	CbGeAlD
Regorafenib—Cardiac disorder—Etoposide—germ cell cancer	0.000222	0.00284	CcSEcCtD
Regorafenib—TEK—midbrain—germ cell cancer	0.00022	0.00221	CbGeAlD
Regorafenib—Decreased appetite—Bleomycin—germ cell cancer	0.000219	0.0028	CcSEcCtD
Regorafenib—ABL1—brainstem—germ cell cancer	0.000218	0.00218	CbGeAlD
Regorafenib—FGFR2—female gonad—germ cell cancer	0.000217	0.00217	CbGeAlD
Regorafenib—PDGFRB—telencephalon—germ cell cancer	0.000217	0.00217	CbGeAlD
Regorafenib—Angiopathy—Etoposide—germ cell cancer	0.000217	0.00278	CcSEcCtD
Regorafenib—FLT1—adrenal gland—germ cell cancer	0.000216	0.00216	CbGeAlD
Regorafenib—Mediastinal disorder—Etoposide—germ cell cancer	0.000216	0.00276	CcSEcCtD
Regorafenib—Pain—Bleomycin—germ cell cancer	0.000215	0.00276	CcSEcCtD
Regorafenib—TEK—spinal cord—germ cell cancer	0.000215	0.00215	CbGeAlD
Regorafenib—RAF1—adrenal gland—germ cell cancer	0.000215	0.00215	CbGeAlD
Regorafenib—Asthenia—Vinblastine—germ cell cancer	0.000214	0.00274	CcSEcCtD
Regorafenib—Infection—Ifosfamide—germ cell cancer	0.000214	0.00274	CcSEcCtD
Regorafenib—EPHA2—female gonad—germ cell cancer	0.000213	0.00214	CbGeAlD
Regorafenib—FLT1—midbrain—germ cell cancer	0.000213	0.00213	CbGeAlD
Regorafenib—Tremor—Cisplatin—germ cell cancer	0.000213	0.00273	CcSEcCtD
Regorafenib—RET—endocrine gland—germ cell cancer	0.000213	0.00213	CbGeAlD
Regorafenib—ABL1—eye—germ cell cancer	0.000212	0.00213	CbGeAlD
Regorafenib—KIT—skin of body—germ cell cancer	0.000212	0.00212	CbGeAlD
Regorafenib—RAF1—midbrain—germ cell cancer	0.000212	0.00212	CbGeAlD
Regorafenib—Alopecia—Etoposide—germ cell cancer	0.000211	0.00271	CcSEcCtD
Regorafenib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000211	0.0027	CcSEcCtD
Regorafenib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000211	0.0027	CcSEcCtD
Regorafenib—KIT—decidua—germ cell cancer	0.000211	0.00211	CbGeAlD
Regorafenib—ABL1—retina—germ cell cancer	0.00021	0.00211	CbGeAlD
Regorafenib—Anaemia—Cisplatin—germ cell cancer	0.00021	0.00269	CcSEcCtD
Regorafenib—RET—head—germ cell cancer	0.00021	0.0021	CbGeAlD
Regorafenib—FGFR1—cerebellum—germ cell cancer	0.000209	0.00209	CbGeAlD
Regorafenib—Skin disorder—Ifosfamide—germ cell cancer	0.000209	0.00268	CcSEcCtD
Regorafenib—TEK—female gonad—germ cell cancer	0.000208	0.00208	CbGeAlD
Regorafenib—KDR—uterus—germ cell cancer	0.000208	0.00208	CbGeAlD
Regorafenib—FLT1—spinal cord—germ cell cancer	0.000208	0.00208	CbGeAlD
Regorafenib—RAF1—bone marrow—germ cell cancer	0.000208	0.00208	CbGeAlD
Regorafenib—PDGFRB—skin of body—germ cell cancer	0.000207	0.00207	CbGeAlD
Regorafenib—RAF1—spinal cord—germ cell cancer	0.000207	0.00207	CbGeAlD
Regorafenib—PDGFRB—decidua—germ cell cancer	0.000206	0.00206	CbGeAlD
Regorafenib—KDR—pituitary gland—germ cell cancer	0.000204	0.00205	CbGeAlD
Regorafenib—Decreased appetite—Dactinomycin—germ cell cancer	0.000204	0.00261	CcSEcCtD
Regorafenib—Diarrhoea—Vinblastine—germ cell cancer	0.000204	0.00261	CcSEcCtD
Regorafenib—Leukopenia—Cisplatin—germ cell cancer	0.000204	0.00261	CcSEcCtD
Regorafenib—RET—testis—germ cell cancer	0.000203	0.00203	CbGeAlD
Regorafenib—Fatigue—Dactinomycin—germ cell cancer	0.000203	0.00259	CcSEcCtD
Regorafenib—PDGFRA—adrenal gland—germ cell cancer	0.000202	0.00203	CbGeAlD
Regorafenib—FGFR2—endocrine gland—germ cell cancer	0.000202	0.00202	CbGeAlD
Regorafenib—FLT1—female gonad—germ cell cancer	0.000201	0.00202	CbGeAlD
Regorafenib—Pain—Dactinomycin—germ cell cancer	0.000201	0.00257	CcSEcCtD
Regorafenib—RAF1—female gonad—germ cell cancer	0.0002	0.002	CbGeAlD
Regorafenib—BRAF—brain—germ cell cancer	0.0002	0.002	CbGeAlD
Regorafenib—FGFR2—head—germ cell cancer	0.000199	0.002	CbGeAlD
Regorafenib—Body temperature increased—Bleomycin—germ cell cancer	0.000199	0.00255	CcSEcCtD
Regorafenib—EPHA2—endocrine gland—germ cell cancer	0.000199	0.00199	CbGeAlD
Regorafenib—KDR—medulla oblongata—germ cell cancer	0.000197	0.00197	CbGeAlD
Regorafenib—EPHA2—head—germ cell cancer	0.000196	0.00196	CbGeAlD
Regorafenib—PDGFRA—spinal cord—germ cell cancer	0.000195	0.00195	CbGeAlD
Regorafenib—TEK—endocrine gland—germ cell cancer	0.000194	0.00194	CbGeAlD
Regorafenib—ABL1—telencephalon—germ cell cancer	0.000194	0.00194	CbGeAlD
Regorafenib—BRAF—lymph node—germ cell cancer	0.000193	0.00193	CbGeAlD
Regorafenib—FGFR2—testis—germ cell cancer	0.000193	0.00193	CbGeAlD
Regorafenib—Anaemia—Etoposide—germ cell cancer	0.000193	0.00247	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000192	0.00246	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000192	0.00246	CcSEcCtD
Regorafenib—TEK—head—germ cell cancer	0.000191	0.00191	CbGeAlD
Regorafenib—EPHX2—brain—germ cell cancer	0.000191	0.00191	CbGeAlD
Regorafenib—Vomiting—Vinblastine—germ cell cancer	0.00019	0.00243	CcSEcCtD
Regorafenib—EPHA2—testis—germ cell cancer	0.000189	0.0019	CbGeAlD
Regorafenib—PDGFRA—female gonad—germ cell cancer	0.000189	0.00189	CbGeAlD
Regorafenib—RET—cerebellum—germ cell cancer	0.000187	0.00187	CbGeAlD
Regorafenib—FLT1—endocrine gland—germ cell cancer	0.000187	0.00187	CbGeAlD
Regorafenib—Decreased appetite—Ifosfamide—germ cell cancer	0.000187	0.0024	CcSEcCtD
Regorafenib—Headache—Vinblastine—germ cell cancer	0.000187	0.00239	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000187	0.00239	CcSEcCtD
Regorafenib—Leukopenia—Etoposide—germ cell cancer	0.000186	0.00239	CcSEcCtD
Regorafenib—RAF1—endocrine gland—germ cell cancer	0.000186	0.00186	CbGeAlD
Regorafenib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000186	0.00238	CcSEcCtD
Regorafenib—Body temperature increased—Dactinomycin—germ cell cancer	0.000186	0.00238	CcSEcCtD
Regorafenib—Abdominal pain—Dactinomycin—germ cell cancer	0.000186	0.00238	CcSEcCtD
Regorafenib—Fatigue—Ifosfamide—germ cell cancer	0.000186	0.00238	CcSEcCtD
Regorafenib—KIT—gonad—germ cell cancer	0.000186	0.00186	CbGeAlD
Regorafenib—FLT1—head—germ cell cancer	0.000185	0.00185	CbGeAlD
Regorafenib—ABL1—skin of body—germ cell cancer	0.000185	0.00185	CbGeAlD
Regorafenib—TEK—testis—germ cell cancer	0.000185	0.00185	CbGeAlD
Regorafenib—EPHX2—lymph node—germ cell cancer	0.000185	0.00185	CbGeAlD
Regorafenib—Infection—Cisplatin—germ cell cancer	0.000184	0.00236	CcSEcCtD
Regorafenib—KIT—uterus—germ cell cancer	0.000184	0.00185	CbGeAlD
Regorafenib—Pain—Ifosfamide—germ cell cancer	0.000184	0.00236	CcSEcCtD
Regorafenib—RAF1—head—germ cell cancer	0.000184	0.00184	CbGeAlD
Regorafenib—ABL1—decidua—germ cell cancer	0.000183	0.00184	CbGeAlD
Regorafenib—KDR—adrenal gland—germ cell cancer	0.000183	0.00183	CbGeAlD
Regorafenib—Nervous system disorder—Cisplatin—germ cell cancer	0.000182	0.00233	CcSEcCtD
Regorafenib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000182	0.00233	CcSEcCtD
Regorafenib—PDGFRB—gonad—germ cell cancer	0.000181	0.00181	CbGeAlD
Regorafenib—KIT—pituitary gland—germ cell cancer	0.000181	0.00181	CbGeAlD
Regorafenib—Asthenia—Bleomycin—germ cell cancer	0.000181	0.00231	CcSEcCtD
Regorafenib—Skin disorder—Cisplatin—germ cell cancer	0.00018	0.00231	CcSEcCtD
Regorafenib—KDR—midbrain—germ cell cancer	0.00018	0.0018	CbGeAlD
Regorafenib—PDGFRB—uterus—germ cell cancer	0.00018	0.0018	CbGeAlD
Regorafenib—Hypertension—Etoposide—germ cell cancer	0.00018	0.0023	CcSEcCtD
Regorafenib—FLT1—testis—germ cell cancer	0.000179	0.00179	CbGeAlD
Regorafenib—FGFR2—cerebellum—germ cell cancer	0.000178	0.00178	CbGeAlD
Regorafenib—RAF1—testis—germ cell cancer	0.000178	0.00178	CbGeAlD
Regorafenib—Nausea—Vinblastine—germ cell cancer	0.000177	0.00227	CcSEcCtD
Regorafenib—PDGFRB—pituitary gland—germ cell cancer	0.000177	0.00177	CbGeAlD
Regorafenib—KDR—bone marrow—germ cell cancer	0.000177	0.00177	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000176	0.00226	CcSEcCtD
Regorafenib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000176	0.00225	CcSEcCtD
Regorafenib—KDR—spinal cord—germ cell cancer	0.000176	0.00176	CbGeAlD
Regorafenib—PDGFRA—endocrine gland—germ cell cancer	0.000175	0.00176	CbGeAlD
Regorafenib—KIT—medulla oblongata—germ cell cancer	0.000175	0.00175	CbGeAlD
Regorafenib—PDGFRA—head—germ cell cancer	0.000173	0.00173	CbGeAlD
Regorafenib—FLT4—brain—germ cell cancer	0.000172	0.00172	CbGeAlD
Regorafenib—PDGFRB—medulla oblongata—germ cell cancer	0.000171	0.00171	CbGeAlD
Regorafenib—TEK—cerebellum—germ cell cancer	0.000171	0.00171	CbGeAlD
Regorafenib—KDR—female gonad—germ cell cancer	0.00017	0.0017	CbGeAlD
Regorafenib—Abdominal pain—Ifosfamide—germ cell cancer	0.00017	0.00218	CcSEcCtD
Regorafenib—Body temperature increased—Ifosfamide—germ cell cancer	0.00017	0.00218	CcSEcCtD
Regorafenib—FGFR1—brain—germ cell cancer	0.00017	0.0017	CbGeAlD
Regorafenib—Infection—Etoposide—germ cell cancer	0.000169	0.00216	CcSEcCtD
Regorafenib—Asthenia—Dactinomycin—germ cell cancer	0.000169	0.00216	CcSEcCtD
Regorafenib—Neutropenia—Methotrexate—germ cell cancer	0.000167	0.00214	CcSEcCtD
Regorafenib—UGT1A1—endocrine gland—germ cell cancer	0.000167	0.00168	CbGeAlD
Regorafenib—PDGFRA—testis—germ cell cancer	0.000167	0.00167	CbGeAlD
Regorafenib—Thrombocytopenia—Etoposide—germ cell cancer	0.000166	0.00213	CcSEcCtD
Regorafenib—FLT4—lymph node—germ cell cancer	0.000166	0.00167	CbGeAlD
Regorafenib—Skin disorder—Etoposide—germ cell cancer	0.000165	0.00211	CcSEcCtD
Regorafenib—FLT1—cerebellum—germ cell cancer	0.000165	0.00165	CbGeAlD
Regorafenib—FGFR1—lymph node—germ cell cancer	0.000164	0.00164	CbGeAlD
Regorafenib—RAF1—cerebellum—germ cell cancer	0.000164	0.00164	CbGeAlD
Regorafenib—KIT—adrenal gland—germ cell cancer	0.000162	0.00162	CbGeAlD
Regorafenib—ABL1—gonad—germ cell cancer	0.000162	0.00162	CbGeAlD
Regorafenib—Decreased appetite—Cisplatin—germ cell cancer	0.000161	0.00207	CcSEcCtD
Regorafenib—Diarrhoea—Dactinomycin—germ cell cancer	0.000161	0.00206	CcSEcCtD
Regorafenib—ABL1—uterus—germ cell cancer	0.000161	0.00161	CbGeAlD
Regorafenib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00016	0.00205	CcSEcCtD
Regorafenib—Vomiting—Bleomycin—germ cell cancer	0.00016	0.00205	CcSEcCtD
Regorafenib—KIT—midbrain—germ cell cancer	0.00016	0.0016	CbGeAlD
Regorafenib—Infestation—Methotrexate—germ cell cancer	0.00016	0.00204	CcSEcCtD
Regorafenib—Infestation NOS—Methotrexate—germ cell cancer	0.00016	0.00204	CcSEcCtD
Regorafenib—Rash—Bleomycin—germ cell cancer	0.000159	0.00203	CcSEcCtD
Regorafenib—Pain—Cisplatin—germ cell cancer	0.000159	0.00203	CcSEcCtD
Regorafenib—Dermatitis—Bleomycin—germ cell cancer	0.000159	0.00203	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000158	0.00203	CcSEcCtD
Regorafenib—KDR—endocrine gland—germ cell cancer	0.000158	0.00158	CbGeAlD
Regorafenib—PDGFRB—adrenal gland—germ cell cancer	0.000158	0.00158	CbGeAlD
Regorafenib—ABL1—pituitary gland—germ cell cancer	0.000158	0.00158	CbGeAlD
Regorafenib—KIT—bone marrow—germ cell cancer	0.000156	0.00157	CbGeAlD
Regorafenib—KDR—head—germ cell cancer	0.000156	0.00156	CbGeAlD
Regorafenib—PDGFRB—midbrain—germ cell cancer	0.000156	0.00156	CbGeAlD
Regorafenib—KIT—spinal cord—germ cell cancer	0.000156	0.00156	CbGeAlD
Regorafenib—Stomatitis—Methotrexate—germ cell cancer	0.000156	0.00199	CcSEcCtD
Regorafenib—ABCG2—trigeminal ganglion—germ cell cancer	0.000155	0.00156	CbGeAlD
Regorafenib—PDGFRA—cerebellum—germ cell cancer	0.000155	0.00155	CbGeAlD
Regorafenib—Asthenia—Ifosfamide—germ cell cancer	0.000154	0.00198	CcSEcCtD
Regorafenib—PDGFRB—bone marrow—germ cell cancer	0.000153	0.00153	CbGeAlD
Regorafenib—PDGFRB—spinal cord—germ cell cancer	0.000152	0.00152	CbGeAlD
Regorafenib—ABL1—medulla oblongata—germ cell cancer	0.000152	0.00152	CbGeAlD
Regorafenib—RET—brain—germ cell cancer	0.000152	0.00152	CbGeAlD
Regorafenib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000151	0.00193	CcSEcCtD
Regorafenib—KDR—testis—germ cell cancer	0.000151	0.00151	CbGeAlD
Regorafenib—KIT—female gonad—germ cell cancer	0.000151	0.00151	CbGeAlD
Regorafenib—Nausea—Bleomycin—germ cell cancer	0.00015	0.00192	CcSEcCtD
Regorafenib—Vomiting—Dactinomycin—germ cell cancer	0.000149	0.00191	CcSEcCtD
Regorafenib—Rash—Dactinomycin—germ cell cancer	0.000148	0.0019	CcSEcCtD
Regorafenib—Decreased appetite—Etoposide—germ cell cancer	0.000148	0.00189	CcSEcCtD
Regorafenib—PDGFRB—female gonad—germ cell cancer	0.000147	0.00147	CbGeAlD
Regorafenib—Diarrhoea—Ifosfamide—germ cell cancer	0.000147	0.00189	CcSEcCtD
Regorafenib—RET—lymph node—germ cell cancer	0.000147	0.00147	CbGeAlD
Regorafenib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000147	0.00188	CcSEcCtD
Regorafenib—Body temperature increased—Cisplatin—germ cell cancer	0.000147	0.00188	CcSEcCtD
Regorafenib—Fatigue—Etoposide—germ cell cancer	0.000147	0.00188	CcSEcCtD
Regorafenib—Pain—Etoposide—germ cell cancer	0.000145	0.00186	CcSEcCtD
Regorafenib—FGFR2—brain—germ cell cancer	0.000145	0.00145	CbGeAlD
Regorafenib—Haemoglobin—Methotrexate—germ cell cancer	0.000144	0.00184	CcSEcCtD
Regorafenib—Haemorrhage—Methotrexate—germ cell cancer	0.000143	0.00184	CcSEcCtD
Regorafenib—EPHA2—brain—germ cell cancer	0.000142	0.00142	CbGeAlD
Regorafenib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000142	0.00181	CcSEcCtD
Regorafenib—ABL1—adrenal gland—germ cell cancer	0.000141	0.00141	CbGeAlD
Regorafenib—Urethral disorder—Methotrexate—germ cell cancer	0.000141	0.0018	CcSEcCtD
Regorafenib—KIT—endocrine gland—germ cell cancer	0.00014	0.0014	CbGeAlD
Regorafenib—Nausea—Dactinomycin—germ cell cancer	0.00014	0.00179	CcSEcCtD
Regorafenib—KDR—cerebellum—germ cell cancer	0.000139	0.0014	CbGeAlD
Regorafenib—Gastrointestinal pain—Etoposide—germ cell cancer	0.000139	0.00178	CcSEcCtD
Regorafenib—ABL1—midbrain—germ cell cancer	0.000139	0.00139	CbGeAlD
Regorafenib—TEK—brain—germ cell cancer	0.000139	0.00139	CbGeAlD
Regorafenib—KIT—head—germ cell cancer	0.000138	0.00139	CbGeAlD
Regorafenib—EPHA2—lymph node—germ cell cancer	0.000137	0.00137	CbGeAlD
Regorafenib—PDGFRB—endocrine gland—germ cell cancer	0.000137	0.00137	CbGeAlD
Regorafenib—Vomiting—Ifosfamide—germ cell cancer	0.000137	0.00175	CcSEcCtD
Regorafenib—ABL1—bone marrow—germ cell cancer	0.000136	0.00136	CbGeAlD
Regorafenib—Rash—Ifosfamide—germ cell cancer	0.000136	0.00174	CcSEcCtD
Regorafenib—ABL1—spinal cord—germ cell cancer	0.000136	0.00136	CbGeAlD
Regorafenib—Dermatitis—Ifosfamide—germ cell cancer	0.000136	0.00174	CcSEcCtD
Regorafenib—Erythema multiforme—Methotrexate—germ cell cancer	0.000136	0.00174	CcSEcCtD
Regorafenib—PDGFRB—head—germ cell cancer	0.000135	0.00135	CbGeAlD
Regorafenib—Body temperature increased—Etoposide—germ cell cancer	0.000134	0.00172	CcSEcCtD
Regorafenib—Abdominal pain—Etoposide—germ cell cancer	0.000134	0.00172	CcSEcCtD
Regorafenib—FLT1—brain—germ cell cancer	0.000134	0.00134	CbGeAlD
Regorafenib—TEK—lymph node—germ cell cancer	0.000134	0.00134	CbGeAlD
Regorafenib—KIT—testis—germ cell cancer	0.000134	0.00134	CbGeAlD
Regorafenib—RAF1—brain—germ cell cancer	0.000133	0.00133	CbGeAlD
Regorafenib—Asthenia—Cisplatin—germ cell cancer	0.000133	0.0017	CcSEcCtD
Regorafenib—Cardiac disorder—Methotrexate—germ cell cancer	0.000133	0.0017	CcSEcCtD
Regorafenib—ABL1—female gonad—germ cell cancer	0.000131	0.00131	CbGeAlD
Regorafenib—PDGFRB—testis—germ cell cancer	0.000131	0.00131	CbGeAlD
Regorafenib—Angiopathy—Methotrexate—germ cell cancer	0.00013	0.00167	CcSEcCtD
Regorafenib—FLT1—lymph node—germ cell cancer	0.000129	0.0013	CbGeAlD
Regorafenib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000129	0.00165	CcSEcCtD
Regorafenib—RAF1—lymph node—germ cell cancer	0.000129	0.00129	CbGeAlD
Regorafenib—Nausea—Ifosfamide—germ cell cancer	0.000128	0.00164	CcSEcCtD
Regorafenib—Diarrhoea—Cisplatin—germ cell cancer	0.000127	0.00163	CcSEcCtD
Regorafenib—Alopecia—Methotrexate—germ cell cancer	0.000127	0.00162	CcSEcCtD
Regorafenib—PDGFRA—brain—germ cell cancer	0.000126	0.00126	CbGeAlD
Regorafenib—Malnutrition—Methotrexate—germ cell cancer	0.000125	0.0016	CcSEcCtD
Regorafenib—ABCB1—blood vessel—germ cell cancer	0.000124	0.00124	CbGeAlD
Regorafenib—KIT—cerebellum—germ cell cancer	0.000124	0.00124	CbGeAlD
Regorafenib—ABL1—endocrine gland—germ cell cancer	0.000122	0.00122	CbGeAlD
Regorafenib—ABCG2—telencephalon—germ cell cancer	0.000122	0.00122	CbGeAlD
Regorafenib—Asthenia—Etoposide—germ cell cancer	0.000122	0.00156	CcSEcCtD
Regorafenib—PDGFRA—lymph node—germ cell cancer	0.000121	0.00121	CbGeAlD
Regorafenib—PDGFRB—cerebellum—germ cell cancer	0.000121	0.00121	CbGeAlD
Regorafenib—ABL1—head—germ cell cancer	0.000121	0.00121	CbGeAlD
Regorafenib—Vomiting—Cisplatin—germ cell cancer	0.000118	0.00151	CcSEcCtD
Regorafenib—Rash—Cisplatin—germ cell cancer	0.000117	0.0015	CcSEcCtD
Regorafenib—Dermatitis—Cisplatin—germ cell cancer	0.000117	0.0015	CcSEcCtD
Regorafenib—ABL1—testis—germ cell cancer	0.000116	0.00117	CbGeAlD
Regorafenib—Diarrhoea—Etoposide—germ cell cancer	0.000116	0.00149	CcSEcCtD
Regorafenib—ABCG2—decidua—germ cell cancer	0.000116	0.00116	CbGeAlD
Regorafenib—Anaemia—Methotrexate—germ cell cancer	0.000115	0.00148	CcSEcCtD
Regorafenib—KDR—brain—germ cell cancer	0.000113	0.00113	CbGeAlD
Regorafenib—Leukopenia—Methotrexate—germ cell cancer	0.000112	0.00143	CcSEcCtD
Regorafenib—Nausea—Cisplatin—germ cell cancer	0.00011	0.00141	CcSEcCtD
Regorafenib—KDR—lymph node—germ cell cancer	0.000109	0.0011	CbGeAlD
Regorafenib—Vomiting—Etoposide—germ cell cancer	0.000108	0.00138	CcSEcCtD
Regorafenib—ABL1—cerebellum—germ cell cancer	0.000108	0.00108	CbGeAlD
Regorafenib—CYP2B6—skin of body—germ cell cancer	0.000107	0.00108	CbGeAlD
Regorafenib—Rash—Etoposide—germ cell cancer	0.000107	0.00137	CcSEcCtD
Regorafenib—Dermatitis—Etoposide—germ cell cancer	0.000107	0.00137	CcSEcCtD
Regorafenib—Headache—Etoposide—germ cell cancer	0.000107	0.00136	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000106	0.00135	CcSEcCtD
Regorafenib—CYP2C8—pituitary gland—germ cell cancer	0.000102	0.00102	CbGeAlD
Regorafenib—ABCG2—uterus—germ cell cancer	0.000101	0.00101	CbGeAlD
Regorafenib—Infection—Methotrexate—germ cell cancer	0.000101	0.0013	CcSEcCtD
Regorafenib—Nausea—Etoposide—germ cell cancer	0.000101	0.00129	CcSEcCtD
Regorafenib—KIT—brain—germ cell cancer	0.0001	0.001	CbGeAlD
Regorafenib—Nervous system disorder—Methotrexate—germ cell cancer	9.99e-05	0.00128	CcSEcCtD
Regorafenib—Thrombocytopenia—Methotrexate—germ cell cancer	9.97e-05	0.00128	CcSEcCtD
Regorafenib—ABCG2—pituitary gland—germ cell cancer	9.94e-05	0.000995	CbGeAlD
Regorafenib—Skin disorder—Methotrexate—germ cell cancer	9.89e-05	0.00127	CcSEcCtD
Regorafenib—PDGFRB—brain—germ cell cancer	9.8e-05	0.000981	CbGeAlD
Regorafenib—KIT—lymph node—germ cell cancer	9.7e-05	0.000971	CbGeAlD
Regorafenib—ABCG2—medulla oblongata—germ cell cancer	9.59e-05	0.00096	CbGeAlD
Regorafenib—PDGFRB—lymph node—germ cell cancer	9.47e-05	0.000948	CbGeAlD
Regorafenib—CYP2B6—gonad—germ cell cancer	9.4e-05	0.000941	CbGeAlD
Regorafenib—CYP2C19—endocrine gland—germ cell cancer	9.07e-05	0.000908	CbGeAlD
Regorafenib—ABCG2—adrenal gland—germ cell cancer	8.88e-05	0.000889	CbGeAlD
Regorafenib—Decreased appetite—Methotrexate—germ cell cancer	8.85e-05	0.00113	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Methotrexate—germ cell cancer	8.79e-05	0.00113	CcSEcCtD
Regorafenib—Fatigue—Methotrexate—germ cell cancer	8.78e-05	0.00112	CcSEcCtD
Regorafenib—ABCG2—midbrain—germ cell cancer	8.77e-05	0.000878	CbGeAlD
Regorafenib—ABL1—brain—germ cell cancer	8.74e-05	0.000874	CbGeAlD
Regorafenib—Pain—Methotrexate—germ cell cancer	8.71e-05	0.00112	CcSEcCtD
Regorafenib—ABCG2—bone marrow—germ cell cancer	8.59e-05	0.00086	CbGeAlD
Regorafenib—ABCG2—spinal cord—germ cell cancer	8.55e-05	0.000856	CbGeAlD
Regorafenib—ABL1—lymph node—germ cell cancer	8.44e-05	0.000845	CbGeAlD
Regorafenib—Gastrointestinal pain—Methotrexate—germ cell cancer	8.33e-05	0.00107	CcSEcCtD
Regorafenib—ABCG2—female gonad—germ cell cancer	8.28e-05	0.000829	CbGeAlD
Regorafenib—CYP2B6—adrenal gland—germ cell cancer	8.19e-05	0.00082	CbGeAlD
Regorafenib—Abdominal pain—Methotrexate—germ cell cancer	8.05e-05	0.00103	CcSEcCtD
Regorafenib—Body temperature increased—Methotrexate—germ cell cancer	8.05e-05	0.00103	CcSEcCtD
Regorafenib—CYP2C8—endocrine gland—germ cell cancer	7.92e-05	0.000793	CbGeAlD
Regorafenib—ABCB1—trigeminal ganglion—germ cell cancer	7.67e-05	0.000767	CbGeAlD
Regorafenib—CYP2C8—testis—germ cell cancer	7.55e-05	0.000756	CbGeAlD
Regorafenib—ABCB1—embryo—germ cell cancer	7.4e-05	0.000741	CbGeAlD
Regorafenib—ABCG2—testis—germ cell cancer	7.34e-05	0.000735	CbGeAlD
Regorafenib—Asthenia—Methotrexate—germ cell cancer	7.31e-05	0.000936	CcSEcCtD
Regorafenib—CYP2B6—endocrine gland—germ cell cancer	7.1e-05	0.000711	CbGeAlD
Regorafenib—CYP2C9—endocrine gland—germ cell cancer	7.03e-05	0.000704	CbGeAlD
Regorafenib—CYP2B6—head—germ cell cancer	7.01e-05	0.000702	CbGeAlD
Regorafenib—Diarrhoea—Methotrexate—germ cell cancer	6.97e-05	0.000892	CcSEcCtD
Regorafenib—ABCG2—cerebellum—germ cell cancer	6.78e-05	0.000679	CbGeAlD
Regorafenib—CYP2B6—testis—germ cell cancer	6.77e-05	0.000678	CbGeAlD
Regorafenib—ABCB1—retina—germ cell cancer	6.54e-05	0.000655	CbGeAlD
Regorafenib—Vomiting—Methotrexate—germ cell cancer	6.48e-05	0.000829	CcSEcCtD
Regorafenib—Rash—Methotrexate—germ cell cancer	6.42e-05	0.000822	CcSEcCtD
Regorafenib—Dermatitis—Methotrexate—germ cell cancer	6.42e-05	0.000821	CcSEcCtD
Regorafenib—Headache—Methotrexate—germ cell cancer	6.38e-05	0.000817	CcSEcCtD
Regorafenib—Nausea—Methotrexate—germ cell cancer	6.05e-05	0.000775	CcSEcCtD
Regorafenib—ABCB1—telencephalon—germ cell cancer	6.02e-05	0.000603	CbGeAlD
Regorafenib—ABCB1—decidua—germ cell cancer	5.71e-05	0.000571	CbGeAlD
Regorafenib—CYP2C8—brain—germ cell cancer	5.67e-05	0.000567	CbGeAlD
Regorafenib—ABCG2—brain—germ cell cancer	5.51e-05	0.000551	CbGeAlD
Regorafenib—CYP3A4—endocrine gland—germ cell cancer	5.36e-05	0.000537	CbGeAlD
Regorafenib—ABCG2—lymph node—germ cell cancer	5.32e-05	0.000533	CbGeAlD
Regorafenib—CYP2B6—brain—germ cell cancer	5.08e-05	0.000509	CbGeAlD
Regorafenib—ABCB1—gonad—germ cell cancer	5.02e-05	0.000503	CbGeAlD
Regorafenib—ABCB1—uterus—germ cell cancer	4.99e-05	0.0005	CbGeAlD
Regorafenib—ABCB1—pituitary gland—germ cell cancer	4.9e-05	0.000491	CbGeAlD
Regorafenib—ABCB1—medulla oblongata—germ cell cancer	4.73e-05	0.000473	CbGeAlD
Regorafenib—ABCB1—adrenal gland—germ cell cancer	4.38e-05	0.000438	CbGeAlD
Regorafenib—ABCB1—midbrain—germ cell cancer	4.32e-05	0.000433	CbGeAlD
Regorafenib—ABCB1—bone marrow—germ cell cancer	4.24e-05	0.000424	CbGeAlD
Regorafenib—ABCB1—spinal cord—germ cell cancer	4.22e-05	0.000422	CbGeAlD
Regorafenib—ABCB1—female gonad—germ cell cancer	4.08e-05	0.000409	CbGeAlD
Regorafenib—ABCB1—endocrine gland—germ cell cancer	3.8e-05	0.00038	CbGeAlD
Regorafenib—ABCB1—head—germ cell cancer	3.75e-05	0.000375	CbGeAlD
Regorafenib—ABCB1—testis—germ cell cancer	3.62e-05	0.000362	CbGeAlD
Regorafenib—ABCB1—cerebellum—germ cell cancer	3.34e-05	0.000335	CbGeAlD
Regorafenib—ABCB1—brain—germ cell cancer	2.72e-05	0.000272	CbGeAlD
Regorafenib—ABCB1—lymph node—germ cell cancer	2.62e-05	0.000263	CbGeAlD
Regorafenib—BRAF—Neuronal System—HRAS—germ cell cancer	1.52e-05	0.000131	CbGpPWpGaD
Regorafenib—RAF1—DAP12 interactions—HRAS—germ cell cancer	1.51e-05	0.000131	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	1.51e-05	0.000131	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR in disease—HRAS—germ cell cancer	1.51e-05	0.000131	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.51e-05	0.000131	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—HRAS—germ cell cancer	1.5e-05	0.00013	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	1.5e-05	0.00013	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—HRAS—germ cell cancer	1.5e-05	0.00013	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—HRAS—germ cell cancer	1.49e-05	0.000129	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.48e-05	0.000129	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—KIT—germ cell cancer	1.48e-05	0.000129	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—HRAS—germ cell cancer	1.48e-05	0.000128	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—FGFR3—germ cell cancer	1.48e-05	0.000128	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—HRAS—germ cell cancer	1.48e-05	0.000128	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—KIT—germ cell cancer	1.46e-05	0.000127	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—H2AFZ—germ cell cancer	1.46e-05	0.000127	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—FGF4—germ cell cancer	1.46e-05	0.000127	CbGpPWpGaD
Regorafenib—FGFR1—Disease—H2AFZ—germ cell cancer	1.45e-05	0.000126	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—H2AFZ—germ cell cancer	1.45e-05	0.000125	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—KITLG—germ cell cancer	1.45e-05	0.000125	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—KITLG—germ cell cancer	1.44e-05	0.000125	CbGpPWpGaD
Regorafenib—FGFR2—Disease—KITLG—germ cell cancer	1.43e-05	0.000124	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—OXT—germ cell cancer	1.43e-05	0.000124	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—HRAS—germ cell cancer	1.43e-05	0.000124	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—FGFR3—germ cell cancer	1.42e-05	0.000123	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—FGFR3—germ cell cancer	1.42e-05	0.000123	CbGpPWpGaD
Regorafenib—RAF1—Immune System—FGF4—germ cell cancer	1.41e-05	0.000122	CbGpPWpGaD
Regorafenib—KIT—Disease—KITLG—germ cell cancer	1.41e-05	0.000122	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—OXT—germ cell cancer	1.4e-05	0.000122	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—H2AFZ—germ cell cancer	1.38e-05	0.00012	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—HRAS—germ cell cancer	1.38e-05	0.000119	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.37e-05	0.000119	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—KIT—germ cell cancer	1.36e-05	0.000118	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—HRAS—germ cell cancer	1.35e-05	0.000117	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—KITLG—germ cell cancer	1.34e-05	0.000117	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	1.34e-05	0.000116	CbGpPWpGaD
Regorafenib—FGFR1—Disease—KITLG—germ cell cancer	1.33e-05	0.000116	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—OXT—germ cell cancer	1.33e-05	0.000116	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—KITLG—germ cell cancer	1.33e-05	0.000115	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—FGF4—germ cell cancer	1.33e-05	0.000115	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—OXT—germ cell cancer	1.33e-05	0.000115	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CRABP1—germ cell cancer	1.33e-05	0.000115	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—FGF4—germ cell cancer	1.32e-05	0.000114	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AVP—germ cell cancer	1.31e-05	0.000114	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—H2AFZ—germ cell cancer	1.3e-05	0.000113	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—KIT—germ cell cancer	1.3e-05	0.000113	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—KIT—germ cell cancer	1.3e-05	0.000113	CbGpPWpGaD
Regorafenib—RAF1—Disease—FGF4—germ cell cancer	1.3e-05	0.000113	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—KITLG—germ cell cancer	1.3e-05	0.000113	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.29e-05	0.000112	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—HRAS—germ cell cancer	1.28e-05	0.000111	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—HRAS—germ cell cancer	1.28e-05	0.000111	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—KITLG—germ cell cancer	1.27e-05	0.00011	CbGpPWpGaD
Regorafenib—ABL1—Immune System—KITLG—germ cell cancer	1.27e-05	0.00011	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—FGFR3—germ cell cancer	1.26e-05	0.000109	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AVP—germ cell cancer	1.24e-05	0.000108	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AVP—germ cell cancer	1.24e-05	0.000107	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—FGF4—germ cell cancer	1.22e-05	0.000106	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SLC2A3—germ cell cancer	1.21e-05	0.000105	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—KITLG—germ cell cancer	1.2e-05	0.000104	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—FGF4—germ cell cancer	1.2e-05	0.000104	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—OXT—germ cell cancer	1.2e-05	0.000104	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SLC22A3—germ cell cancer	1.19e-05	0.000104	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—H2AFZ—germ cell cancer	1.19e-05	0.000103	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—H2AFZ—germ cell cancer	1.18e-05	0.000102	CbGpPWpGaD
Regorafenib—RAF1—Disease—H2AFZ—germ cell cancer	1.16e-05	0.000101	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—HRAS—germ cell cancer	1.16e-05	0.000101	CbGpPWpGaD
Regorafenib—RAF1—Immune System—KITLG—germ cell cancer	1.16e-05	0.0001	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—HRAS—germ cell cancer	1.15e-05	0.0001	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—KIT—germ cell cancer	1.15e-05	9.99e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—FGFR3—germ cell cancer	1.15e-05	9.99e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—FGFR3—germ cell cancer	1.15e-05	9.95e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—FGF4—germ cell cancer	1.14e-05	9.86e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—FGF4—germ cell cancer	1.13e-05	9.84e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—FGFR3—germ cell cancer	1.13e-05	9.81e-05	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—HRAS—germ cell cancer	1.13e-05	9.76e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—KITLG—germ cell cancer	1.09e-05	9.47e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—H2AFZ—germ cell cancer	1.09e-05	9.45e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—KITLG—germ cell cancer	1.08e-05	9.38e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—FGFR3—germ cell cancer	1.07e-05	9.31e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—FGFR3—germ cell cancer	1.07e-05	9.29e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—H2AFZ—germ cell cancer	1.07e-05	9.28e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—KITLG—germ cell cancer	1.07e-05	9.27e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AVP—germ cell cancer	1.07e-05	9.25e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—OXT—germ cell cancer	1.07e-05	9.25e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—FGFR3—germ cell cancer	1.06e-05	9.23e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—KIT—germ cell cancer	1.06e-05	9.17e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AVP—germ cell cancer	1.06e-05	9.17e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—KIT—germ cell cancer	1.05e-05	9.14e-05	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—HRAS—germ cell cancer	1.05e-05	9.09e-05	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—HRAS—germ cell cancer	1.05e-05	9.06e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—FGFR3—germ cell cancer	1.05e-05	9.06e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—HRAS—germ cell cancer	1.03e-05	8.91e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.03e-05	8.9e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—FGF4—germ cell cancer	1.02e-05	8.86e-05	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—HRAS—germ cell cancer	1.02e-05	8.82e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—H2AFZ—germ cell cancer	1.02e-05	8.81e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—H2AFZ—germ cell cancer	1.01e-05	8.78e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.01e-05	8.77e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—KITLG—germ cell cancer	1e-05	8.69e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—FGFR3—germ cell cancer	9.99e-06	8.66e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—FGFR3—germ cell cancer	9.92e-06	8.6e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—FGFR3—germ cell cancer	9.89e-06	8.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—KIT—germ cell cancer	9.86e-06	8.55e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—KITLG—germ cell cancer	9.85e-06	8.54e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—KIT—germ cell cancer	9.84e-06	8.53e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AVP—germ cell cancer	9.8e-06	8.5e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—KIT—germ cell cancer	9.77e-06	8.47e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CRABP1—germ cell cancer	9.74e-06	8.44e-05	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—HRAS—germ cell cancer	9.69e-06	8.4e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—FGFR3—germ cell cancer	9.66e-06	8.37e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AVP—germ cell cancer	9.63e-06	8.34e-05	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—MYC—germ cell cancer	9.61e-06	8.33e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—FGFR3—germ cell cancer	9.44e-06	8.18e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—FGFR3—germ cell cancer	9.41e-06	8.16e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—KITLG—germ cell cancer	9.35e-06	8.1e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—KITLG—germ cell cancer	9.32e-06	8.08e-05	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—HRAS—germ cell cancer	9.3e-06	8.06e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—KIT—germ cell cancer	9.17e-06	7.95e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC2A3—germ cell cancer	9.17e-06	7.95e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AVP—germ cell cancer	9.14e-06	7.92e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—H2AFZ—germ cell cancer	9.13e-06	7.91e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AVP—germ cell cancer	9.11e-06	7.9e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGF4—germ cell cancer	9.11e-06	7.9e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—KIT—germ cell cancer	9.11e-06	7.9e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—KIT—germ cell cancer	9.08e-06	7.87e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC22A3—germ cell cancer	9.03e-06	7.83e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC2A3—germ cell cancer	8.95e-06	7.76e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—FGFR3—germ cell cancer	8.91e-06	7.73e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—KIT—germ cell cancer	8.86e-06	7.68e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC22A3—germ cell cancer	8.81e-06	7.64e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	8.81e-06	7.64e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—KIT—germ cell cancer	8.67e-06	7.51e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—KIT—germ cell cancer	8.64e-06	7.49e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—FGFR3—germ cell cancer	8.61e-06	7.46e-05	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—HRAS—germ cell cancer	8.55e-06	7.41e-05	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	8.52e-06	7.39e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—KITLG—germ cell cancer	8.4e-06	7.28e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC2A3—germ cell cancer	8.36e-06	7.25e-05	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—HRAS—germ cell cancer	8.29e-06	7.18e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CRABP1—germ cell cancer	8.25e-06	7.15e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC22A3—germ cell cancer	8.23e-06	7.14e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AVP—germ cell cancer	8.21e-06	7.12e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—KIT—germ cell cancer	8.18e-06	7.09e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—H2AFZ—germ cell cancer	8.14e-06	7.05e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—FGFR3—germ cell cancer	8.12e-06	7.04e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—FGFR3—germ cell cancer	8.04e-06	6.97e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—FGFR3—germ cell cancer	7.95e-06	6.89e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—KIT—germ cell cancer	7.9e-06	6.85e-05	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TP53—germ cell cancer	7.89e-06	6.84e-05	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—HRAS—germ cell cancer	7.85e-06	6.81e-05	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—HRAS—germ cell cancer	7.71e-06	6.69e-05	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HRAS—germ cell cancer	7.55e-06	6.54e-05	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HRAS—germ cell cancer	7.54e-06	6.54e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—KITLG—germ cell cancer	7.49e-06	6.49e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—KIT—germ cell cancer	7.45e-06	6.46e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—FGFR3—germ cell cancer	7.45e-06	6.46e-05	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TP53—germ cell cancer	7.44e-06	6.45e-05	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HRAS—germ cell cancer	7.41e-06	6.42e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—KIT—germ cell cancer	7.38e-06	6.4e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CRABP1—germ cell cancer	7.36e-06	6.38e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—FGFR3—germ cell cancer	7.32e-06	6.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—HRAS—germ cell cancer	7.32e-06	6.34e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AVP—germ cell cancer	7.32e-06	6.34e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—HRAS—germ cell cancer	7.3e-06	6.33e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—KIT—germ cell cancer	7.29e-06	6.32e-05	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—HRAS—germ cell cancer	7.26e-06	6.29e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CRABP1—germ cell cancer	7.18e-06	6.23e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MYC—germ cell cancer	7.17e-06	6.21e-05	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—HRAS—germ cell cancer	7.12e-06	6.17e-05	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HRAS—germ cell cancer	7.03e-06	6.09e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HRAS—germ cell cancer	7.01e-06	6.08e-05	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7e-06	6.07e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—FGFR3—germ cell cancer	6.95e-06	6.02e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—FGFR3—germ cell cancer	6.93e-06	6.01e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—KIT—germ cell cancer	6.84e-06	5.93e-05	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—germ cell cancer	6.81e-06	5.9e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CRABP1—germ cell cancer	6.71e-06	5.82e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—HRAS—germ cell cancer	6.64e-06	5.75e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—HRAS—germ cell cancer	6.58e-06	5.7e-05	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—HRAS—germ cell cancer	6.51e-06	5.64e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—HRAS—germ cell cancer	6.41e-06	5.56e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—KIT—germ cell cancer	6.38e-06	5.53e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—KIT—germ cell cancer	6.36e-06	5.51e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HRAS—germ cell cancer	6.32e-06	5.47e-05	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—MYC—germ cell cancer	6.31e-06	5.47e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—FGFR3—germ cell cancer	6.24e-06	5.41e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—germ cell cancer	5.89e-06	5.1e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—HRAS—germ cell cancer	5.86e-06	5.08e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—MYC—germ cell cancer	5.8e-06	5.03e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—KIT—germ cell cancer	5.73e-06	4.97e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HRAS—germ cell cancer	5.63e-06	4.88e-05	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HRAS—germ cell cancer	5.63e-06	4.88e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGFR3—germ cell cancer	5.56e-06	4.82e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	5.51e-06	4.78e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	5.43e-06	4.71e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—MYC—germ cell cancer	5.38e-06	4.66e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—MYC—germ cell cancer	5.28e-06	4.58e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—KIT—germ cell cancer	5.11e-06	4.43e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MYC—germ cell cancer	5.05e-06	4.37e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—MYC—germ cell cancer	5.01e-06	4.34e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—MYC—germ cell cancer	5e-06	4.33e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HRAS—germ cell cancer	4.98e-06	4.32e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MYC—germ cell cancer	4.77e-06	4.13e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HRAS—germ cell cancer	4.57e-06	3.96e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—HRAS—germ cell cancer	4.56e-06	3.95e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—MYC—germ cell cancer	4.5e-06	3.9e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—HRAS—germ cell cancer	4.49e-06	3.89e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CRABP1—germ cell cancer	4.43e-06	3.84e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HRAS—germ cell cancer	4.26e-06	3.7e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HRAS—germ cell cancer	4.25e-06	3.69e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—HRAS—germ cell cancer	4.22e-06	3.66e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—HRAS—germ cell cancer	4.15e-06	3.6e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—germ cell cancer	4.14e-06	3.59e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MYC—germ cell cancer	4.1e-06	3.56e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MYC—germ cell cancer	4.06e-06	3.52e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—MYC—germ cell cancer	4.01e-06	3.48e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HRAS—germ cell cancer	3.96e-06	3.44e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—HRAS—germ cell cancer	3.94e-06	3.41e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—HRAS—germ cell cancer	3.93e-06	3.4e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—germ cell cancer	3.92e-06	3.4e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HRAS—germ cell cancer	3.83e-06	3.32e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MYC—germ cell cancer	3.77e-06	3.26e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HRAS—germ cell cancer	3.75e-06	3.25e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HRAS—germ cell cancer	3.74e-06	3.24e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HRAS—germ cell cancer	3.73e-06	3.24e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MYC—germ cell cancer	3.7e-06	3.21e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—HRAS—germ cell cancer	3.54e-06	3.07e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MYC—germ cell cancer	3.51e-06	3.04e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MYC—germ cell cancer	3.5e-06	3.03e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HRAS—germ cell cancer	3.41e-06	2.96e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—germ cell cancer	3.37e-06	2.92e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—germ cell cancer	3.34e-06	2.89e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HRAS—germ cell cancer	3.22e-06	2.79e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HRAS—germ cell cancer	3.19e-06	2.77e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MYC—germ cell cancer	3.15e-06	2.73e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—HRAS—germ cell cancer	3.15e-06	2.73e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—germ cell cancer	3.09e-06	2.68e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—germ cell cancer	3.04e-06	2.63e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HRAS—germ cell cancer	2.96e-06	2.56e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HRAS—germ cell cancer	2.9e-06	2.52e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—germ cell cancer	2.88e-06	2.5e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—germ cell cancer	2.87e-06	2.49e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MYC—germ cell cancer	2.81e-06	2.44e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HRAS—germ cell cancer	2.76e-06	2.39e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HRAS—germ cell cancer	2.75e-06	2.38e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—germ cell cancer	2.59e-06	2.24e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HRAS—germ cell cancer	2.48e-06	2.15e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—germ cell cancer	2.31e-06	2e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HRAS—germ cell cancer	2.21e-06	1.91e-05	CbGpPWpGaD
